Pre-exercise administration of yohimbine may enhance the efficacy of exercise training as a fat loss strategy by boosting lipolysis

Medical Hypotheses

Volumn 58, Issue 6, 2002, Pages 491-495

  McCarty, Mark F ^a  

^a Pantox Laboratories   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENERGIC RECEPTOR STIMULATING AGENT; ALPHA 2 ADRENERGIC RECEPTOR; CAFFEINE; EPHEDRINE; LIPOPROTEIN LIPASE; YOHIMBINE;

ADIPOCYTE; ANXIETY NEUROSIS; DRUG POTENTIATION; ENZYME REGULATION; EXERCISE; FATTY ACID BLOOD LEVEL; HUMAN; HYPERTENSION; INSULIN RELEASE; LIPOLYSIS; OBESITY; PRIORITY JOURNAL; RESPIRATORY QUOTIENT; REVIEW; SYMPATHETIC TONE;

EID: 0036618843     PISSN: 03069877     EISSN: None     Source Type: Journal    
DOI: 10.1054/mehy.2001.1459     Document Type: Article

References (37)

1. Effects of caffeine ingestion on metabolism and exercise performance
2. Caffeine and endurance performance
3. Caffeine ingestion prior to incremental cycling to exhaustion in recreational cyclists
4. The effects of two levels of caffeine ingestion on excess postexercise oxygen consumption in untrained women
5. Dietary fat, carbohydrate balance, and weight maintenance: Effects of exercise
6. Optimizing exercise for fat loss
7. Pyruvate and hydroxycitrate/carnitine may synergize to promote reverse electron transport in hepatocyte mitochondria, effectively 'uncoupling' the oxidation of fatty acids
8. BRL 49653 blocks the lipolytic actions of tumor necrosis factor-alpha: A potential new insulin-sensitizing mechanism for thiazolidinediones
9. Yohimbine in erectile dysfunction: The facts
10. Adrenergic control of lipolysis and metabolic responses in obesity
11. Alpha 2-antagonist compounds and lipid mobilization: Evidence for a lipid mobilizing effect of oral yohimbine in healthy male volunteers
12. Plasma catecholamine levels and lipid mobilization induced by yohimbine in obese and non-obese women
13. Alpha-2 adrenoceptors in lipolysis: Alpha 2 antagonists and lipid-mobilizing strategies
14. Yohimbine use in a natural setting: Effects on posttraumatic stress disorder
15. The alpha-2 adrenoceptor antagonist yohimbine does not facilitate weight loss but blocks adrenaline induced platelet aggregation in obese subjects
16. Effect of systemic alpha-2 adrenergic blockade on the morning increase in platelet aggregation in normal subjects
17. Benign course after massive ingestion of yohimbine
18. Adrenoceptor antagonists, but not guanethidine, reduce glucopenia-induced glucagon secretion from perfused rat pancreas
19. Does yohimbine act as a slimming drug?
20. Yohimbine does not affect fat distribution in men
21. Role of fatty acids in the pathogenesis of insulin resistance and NIDDM
22. Overnight lowering of free fatty acids with Acipimox improves insulin resistance and glucose tolerance in obese diabetic and nondiabetic subjects
23. Pharmacodynamic effects of chronic yohimbine treatment in healthy volunteers
24. The effect and safety of an ephedrine/caffeine compound compared to ephedrine, caffeine and placebo in obese subjects on an energy restricted diet: A double blind trial
25. Presynaptic inhibition of norepinephrine release from sympathetic nerve endings by endogenous adenosine
26. Presynaptic inhibition of norepinephrine release from sympathetic nerve endings by endogenous adenosine
27. Interactions between the presynaptic alpha2-autoreceptor and presynaptic inhibitory heteroreceptors on noradrenergic neurones
28. Al-adenosine receptor-mediated inhibition of adipocyte adenylate cyclase and lipolysis in Zucker rats
29. Beta-adrenergic-cyclic AMP signalling pathway modulates cell function at the transcriptional level in 3T3-F442A adipocytes
30. Alpha-adrenergic antilipolytic effect of adrenaline in human fat cells of the thigh: Comparison with adrenaline responsiveness of different fat deposits
31. Regional differences in the control of lipolysis in human adipose tissue
32. Heterogeneous distribution of beta and alpha-2 adrenoceptor binding sites in human fat cells from various fat deposits: Functional consequences
33. Marked reduction of acyl-CoA synthetase activity and mRNA in intra-abdominal visceral fat by physical exercise
34. Pathophysiology and molecular mechanisms of visceral fat syndrome: The Japanese experience
35. Lipolytic catecholamine resistance linked to alpha 2-adrenoceptor sensitivity - A metabolic predictor of weight loss in obese subjects
36. Catecholamine-induced lipolysis in adipose tissue of the elderly
37. Aging, fat oxidation and exercise